Current Edition


Key Bristol Myers drug holds up in long-term psoriasis study

Dive Brief: An experimental psoriasis drug developed by Bristol Myers Squibb maintained its effectiveness over more than a year of treatment in a clinical trial …

Continue Reading →

Lilly’s new eczema drug scores in late-stage studies

Once known primarily for its work in diabetes, Lilly has, for years now, been branching into other areas of drug development like immunology. There, the …

Continue Reading →